Why it was recalled
Presence of Foreign Tablets/Capsules
Product description
Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-21
Lot numbers, UPCs & expiration codes
Lot #: 1019594, Exp. Date 12/31/2025
Where it was sold
Nationwide within the United States
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0184-2025
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Dec 13, 2024
- FDA report date
- Jan 15, 2025
- Quantity
- 5,178 cartons
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Amerisource Health Services LLC
Original FDA data
Every field from FDA enforcement report D-0184-2025, exactly as published.
Show all FDA fields
- City
- Columbus
- State
- OH
- Status
- Ongoing
- Country
- United States
- Event ID
- 96017
- Address
- 2550 John Glenn Ave Ste A
- Code information
- Lot #: 1019594, Exp. Date 12/31/2025
- Postal code
- 43217-1188
- Report date
- Jan 15, 2025
- Product type
- Drugs
- Recall number
- D-0184-2025
- Classification
- Class II
- Recalling firm
- Amerisource Health Services LLC
- Product quantity
- 5,178 cartons
- Reason for recall
- Presence of Foreign Tablets/Capsules
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Clobazam Tablets, 10 mg, packaged in 30 tablets per carton (3x10 blister cards each), Rx Only, Amneal Pharmaceuticals LLC, Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 60687-423-21
- Distribution pattern
- Nationwide within the United States
- Recall initiation date
- Dec 13, 2024
- Initial firm notification
- Letter
- Center classification date
- Jan 6, 2025